Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Case report · 29 Jul 2016Exact title match Article · 20 Feb 2014 Clinical significance of fibroblast growth factor receptor-3 mutations in bladder cancer: a systematic review and meta-analysis..
Mutations in the fibroblast growth factor receptor-3 (FGFR3) gene are frequently found in bladder cancer, but their prognostic value remains controversial. To globally summarize the association between FGFR3 mutations…
Perspective · 30 Sep 2022 Editorial Note on Non-Muscle-Invasive Bladder Cancer
Bladder cancer refers to any of numerous kinds of cancer that develop in the tissues of the urinary bladder. Blood in the pee, urinating pain, and low back pain ... symptoms. Smoking, a family history of bladder cancer…
Short communication · 1 Jul 2018 Survivin and caspase-3 as diagnostic and predictive biomarkers of recurrence for urinary bladder carcinoma after transurethral resection of bladder tumor
Bladder cancer is one amongst the foremost common cancers, moving about sixty 68,000 adults within the US every year. Bladder cancer happens in men additional often than it will ... girls and frequently affects older…
Editorial · 29 Oct 2024 Managing Bladder Cancer: Diagnostic Steps and Treatment Strategies
Bladder cancer management requires a thorough understanding of both diagnostic procedures and treatment strategies. Accurate diagnosis is achieved through a combination of medical history, physical examinations…
Research article · 1 Aug 2017 High urine miR-126 level predicts bladder cancer in hematuria patients
Objective: Bladder cancer is one of the commonest genitourinary tumors all over the world. The early detection rate was still very low due to the lack of effective diagnostic biomarkers ... examined the feasibility and…
Case report · Apr 2021 Cisplatin Based Chemotherapy for Non Muscle Invasive Bladder Cancer: Synchronous Gall Bladder Cancer Takes Care of the Other Bladder
mass. She was managed with radical cholecystectomy and adjuvant platinum-based chemotherapy for gall bladder cancer. A transurethral resection of the bladder tumor was done followed by intravesical ... muscle invasive…
Conference abstract · 15 Jul 2013 At-home bladder cancer detection kit: Urine gelatinase activity as a biomarker for bladder cancer
applied this method to test the urine of 39 patients including 17 patients with bladder cancer, 11 with prostate cancer, 9 with squamous cancer of the head and neck ... with renal cell carcinoma. In 82 % of the bladder…
Conference abstract · 2018 Exploring the clinical toxicology of intravesical chemotherapy for patients with non-invasive bladder cancer: A population-based analysis of bladder cancer in Taiwan
Bladder cancer is the most common malignant tumor of the urinary tract, treatment for superficial non-invasive bladder carcinoma is currently using intravesical chemotherapy and this treatment regimen provides ... urine…
Article · 2016 4-Aminobiphenyl and Nitric Oxide Synergistically Modified Human DNA: Itandrsquo;s Implication in Bladder Cancer
Bladder cancer is a disease of continuing public health significance. Some known risk factors for bladder cancer development include smoking, occupational exposure, genetic susceptibility, infectious diseases and…
Article · 20 Jan 2024 Role and Molecular Mechanisms of S100A9 Underlying Gemcitabine Chemoresistance in Bladder Cancer
Bladder cancer cells become resistant to gemcitabine chemotherapy, S100A9 is involved in cancer progression and associated with chemo resistance, but the mechanism of S100A9’s role in gemcitabine chemo resistance…
Research article · 17 Aug 2010 Meta-analysis of epidemiological studies of association of P53 codon 72 polymorphism with bladder cancer
many studies investigating a possible association between p53 codon 72 polymorphism and risk of bladder cancer, the results have been inconsistent. We conducted a meta-analysis of six epidemiological studies ... which…
Research article · 2015 Does Pioglitazone Increase the Risk of Bladder Cancer in Japanese Diabetic Patients?
Abstract Objective: To investigate the risk of bladder cancer with pioglitazone, the data of diabetic patients treated at Teikyo Chiba Medical Center were analyzed retrospectively. Methods: From February ... treated…
Research article · 27 Apr 2015 CYFRA21-1 levels could be a biomarker for bladder cancer: a meta-analysis
whether urinary or serum samples containing CYFRA21-1 can be used as biomarkers for bladder cancer, we conducted a comprehensive meta-analysis of 3 case-control studies. In all studies ... considered, patients with…
Research article · 14 Dec 2015 Meta-analysis of the relationship between slow acetylation of N-acetyl transferase 2 and the risk of bladder cancer
incidence of bladder cancer is closely associated with exposure to aromatic amines, that can cause cancer only after metabolic activation regulated by N-acetyl transferase 1 and 2 (NAT1 ... NAT2). Many studies have…
Review article · 27 Oct 2022 Bladder cancer cells' migration and proliferation are suppressed by EDARADD silencing.
Bladder cancer could be a quite common malignant cancer within the urinary apparatus. The expression of EDARADD (ectodysplasin-A receptor-associated death domain) in bladder cancer is beyond the conventional…
Review article · 2020 Association of Additive Risk of Pioglitazone Use with the Presence of CYP1A1 Polymorphisms in the Occurrence of Bladder Cancer
causes. Certain polymorphism of CYP1A1 gene recently has been linked to the occurrence of bladder cancer. Pioglitazone that used for treatment of diabetes mellitus type II for long time carry ... Materials and method…
Article · 15 Nov 2023 The Role of pD_L1 expression in bladder cancer
this study is to determine the expression of the PD_L1protein in human bladder cancer, and significant correlations between these parameters and clinico pathologic variables like (grade and stage ... also by using this…
Article · 30 Nov 2023 Prognostic value of FGFR3 expression in Urinary bladder cancer
this study is to determine the expression of the FGFR3protein in human bladder cancer, and significant correlations between these parameters and clinico pathologic variables like (grade and stage. the bladder…
Research article · 12 Sep 2012 Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk
rs1052133) in the human 8-oxoguanine DNA glycosylase (hOGG1) gene has been implicated in bladder cancer risk. However, reports of this association between the Ser326Cys polymorphism and bladder cancer risk ... strength…
Review article · 27 Feb 2023 Challenges in Bladder Carcinoma Treatment and Immunotherapy's Future Bladder Cancer: Current Challenges and Future Directions
subtypes of TCC according to histopathology (MIBC). NMIBC makes up around 75% of bladder cancer cases with recent diagnoses. These tumours are limited to the bladder's mucosal or submucosal ... sizable portion of NMIBC…
Mini review · 30 May 2024 Navigating the Maze: Understanding Bladder Cancer Diagnosis
Bladder cancer represents a significant health concern worldwide, with a high incidence rate and substantial mortality. Early detection and accurate diagnosis are paramount for improving patient outcomes and reducing…
Research article · 21 Dec 2015 Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer
immunohistochemistry, and the expressions of CXCR4 and CXCL12 mRNAs were detected by RT-PCR. Bladder cancer tissues showed higher positive expressions of CXCR4 and CXCL12 than those in normal bladder ... expression of…
Research article · 25 Aug 2023 Surgical therapeutic approaches to bladder cancer
Bladder cancer is the uncontrolled proliferation of bladder cells, causing the formation of heterogeneous lesions. It is ranked second after prostate cancer in men and it is the first genitourinary ... women. The study…
Commentary · 30 Sep 2024 Bladder Cancer Prognosis and Treatment: The Impact of Genetic Markers
Bladder cancer remains one of the most common malignancies globally, with significant variability in patient outcomes. Recent advancements in genetic research have highlighted the pivotal role of genetic markers…
Article · 29 Aug 2024 Exploring the therapeutic potential of esculin in the treatment of bladder cancer
Bladder cancer is a type of cancer that arises in the bladder’s epithelial lining. It is distinguished by the bladder’s cells growing beyond control. Esculin is a naturally ... have therapeutic effects on a number of…

